GENE ONLINE|News &
Opinion
Blog

NSCLC
Editors' Picks weekly highlights
GeneOnline’s Weekly News Highlights: Nov 13-Nov 17
2023-11-20
Editors' Picks weekly highlights
GeneOnline’s Weekly News Highlights: Oct 16-Oct 20
2023-10-24
Special ASCOOncology
2023 ASCO Annual Meeting: Progress in Solid Tumor Treatment Research, and Promising Results in Emerging Therapies
2023-07-03
Interviews Lung CancerNSCLC
Strengthening Genetic Screening Platform in APAC for Lung Cancer Precision Medicine: An Interview with Dr. Koichi Goto
2023-06-05
Trials & Approvals Keytruda
Merck’s Keytruda Falls Short In Two Trials
2023-03-01
Trials & Approvals NSCLC
Junshi’s PD-1 Antibody Meets Endpoint In Phase 3 Lung Cancer Trial
2023-01-19
Trials & Approvals Merck
Merck Presents Positive News For Keytruda Combination in NSCLC
2022-09-13
Trials & Approvals NSCLC
Jounce’s Antibody Misses Primary Endpoint In Phase 2 Lung Cancer Study
2022-08-31
Trials & Approvals Lung Cancer
Novartis’s Lung Cancer Drug Approved for Marketing in Europe
2022-06-23
M&A Bristol Myers Squibb
BMS Buys Turning Point Therapeutics For $4.1 Billion, Bringing In Lung Cancer Drug
2022-06-06
Deals Cancer Vaccine
BioNTech and Regeneron Expands Cancer Vaccine Collab, Adds Lung Cancer Indication
2022-03-10
Special
ESMO21: Latest Clinical Studies Answer Central Questions in the Treatment of Leading Cancers
2021-09-22
Special
EQRx, CStone’s Low-Cost anti-PD-L1 Inhibitor Flaunts Encouraging Data in Stage 3 NSCLC
2021-09-19
Trials & Approvals Lung Cancer
NHS to Roll Out Revolutionary Lung Cancer Drug Targeting the Once ‘Undruggable’ KRAS
2021-09-12
Trials & Approvals
J&J’s FDA-Approved Bispecific Antibody Registers Promising Phase 1 Results for a Different Indication
2021-08-20
1 2 3 4
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
READ MORE
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top